Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...

Below are the five worst data breaches we saw in 2024: It’s called the Mother of all Data Breaches for a reason – 2.6 billion ...

Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

Now, China-based CARsgen has shared pivotal results from the latter portion of a phase 1/2 study evaluating the therapy for ...

The company has roaming agreements with 400+ cellular carriers worldwide, which are accessible from over 200 cruise ships. In those cases, travelers’ devices will automatically connect to the network ...

A new Opinium survey of 2,000 UK adults, which was commissioned by Uswitch.com and conducted on 7th Jan 2025, has claimed ...

Imugene has dosed the first Australian subject in a Phase Ib trial of its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel).

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

VMT-a-NET is under clinical development by Perspective Therapeutics and currently in Phase II for Small-Cell Lung Cancer.

A planning commission in a Virginia county has voted unanimously to recommend denial of a rezoning application from Balico ...

Customers at the four major mobile phone networks have been issued a warning ahead of a huge service change this year, as we ...